Sterling Capital Management’s Sanara MedTech SMTI Stock Holding History

Sterling Capital Management’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283	Sell	12 -8	-40%	-$165	﹤0.01%	3253
2026 Q1	$344	Hold	20	–	–	﹤0.01%	3179
2025 Q4	$467	Buy	20 +13	+186%	+$336	﹤0.01%	3198
2025 Q3	$222	Sell	7 -2	-22%	-$60	﹤0.01%	3209
2025 Q2	$256	Buy	9 +6	+200%	+$180	﹤0.01%	3219
2025 Q1	$93	Hold	3	–	–	﹤0.01%	3149
2024 Q4	$100	Hold	3	–	–	﹤0.01%	3180
2024 Q3	$91	Buy	+3	New	+$94	﹤0.01%	3198

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Sterling Capital Management's SMTI Position: Q2 2026 in Review

Sterling Capital Management reduced its Sanara MedTech (SMTI) stake by 40% in Q2 2026, selling an estimated $165 and leaving 12 shares worth $283. The position accounts for ﹤0.01% of the portfolio, ranked #3253.

Sterling Capital Management first reported a position in SMTI in Q3 2024 and has held it in 8 quarters since. The position peaked at $467 in Q4 2025. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Sterling Capital Management held 12 shares of Sanara MedTech worth $283 as of Q2 2026.
Sterling Capital Management sold 8 Sanara MedTech shares in Q2 2026, an estimated $165.
Sanara MedTech made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3253 holding.
Sterling Capital Management first reported a position in Sanara MedTech in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's Sanara MedTech position peaked at $467 in Q4 2025.
75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.